News

Filter

Current filters:

PharmaceuticalPfizer

1 to 9 of 723 results

Positive results for Pfizer’s Prevenar 13 for community acquired pneumonia

Positive results for Pfizer’s Prevenar 13 for community acquired pneumonia

19-03-2015

US pharma giant Pfizer says that positive findings from its Community-Acquired Pneumonia Immunization…

Antibiotics and Infectious diseasesPfizerPharmaceuticalPrevenarResearchVaccines

Pfizer’s Lyrica fails in adolescents with fibromyalgia

13-03-2015

US pharma giant Pfizer today released disappointing top-line results of a double-blind Phase IV study…

LyricaNeurologicalPfizerPharmaceuticalResearch

FDA updates label on Pfizer's Chantix to warn of interaction with alcohol

FDA updates label on Pfizer's Chantix to warn of interaction with alcohol

10-03-2015

The US Food and Drug Administration has updated the label on Chantix (varenicline), marketed by Pfizer,…

ChantixNeurologicalPfizerPharmaceuticalRegulationUSA

NICE draft guidance recommends Eliquis for treating and preventing potentially fatal blood clots

NICE draft guidance recommends Eliquis for treating and preventing potentially fatal blood clots

06-03-2015

In draft guidance published today, the National Institute for Health and care Excellence (NICE), the…

Bristol-Myers SquibbCardio-vascularEliquisPfizerPharmaceuticalPricingRegulationUK

Pfizer receives European approval for Prevenar 13 expanded indication

Pfizer receives European approval for Prevenar 13 expanded indication

04-03-2015

The European Commission has approved an expanded indication for the world’s most most widely used pneumococcal…

Anti-viralsEuropePfizerPharmaceuticalPrevenarRegulation

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

NICE recommends Pfizer's Inlyta but not Dendreon's Provenge

25-02-2015

The UK’s National Institute for Health and Care Excellence has recommended Inlyta (axitinib), marketed…

DendreonInlytaOncologyPfizerPharmaceuticalPricingProvengeRegulationUKValeant Pharmaceuticals International

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

24-02-2015

US pharma giant Pfizer has announced positive top-line results of a Phase II study of Trumenba (meningococcal…

Antibiotics and Infectious diseasesPfizerPharmaceuticalResearchTrumenbaUSA

Vaccines a $25.5 billion business in 2014; report

Vaccines a $25.5 billion business in 2014; report

13-02-2015

Vaccines are a big business, and a growing business, says health care market researcher Kalorama Information,…

GlaxoSmithKlineMarkets & MarketingMerck & CoNovartisPfizerPharmaceuticalSanofiVaccines

1 to 9 of 723 results

Back to top